We have developed a method to evaluate the diffusion of ammonia across the blood-brain barrier (BBB) in normal humans, based on measures of CBF and the regional cerebral metabolic rate for ammonia, ob tained by positron emission tomography. The extraction fraction for ammonia passing through the cerebral capil lary bed was a reciprocal function of CBF. The product of the BBB surface area and ammonia permeability. cal culated from the Renkin-Crone model, was 0.32 ± 0.19 cm3 g-I min -I (± SD) in gray matter and 0.24 ± 0.16 cm3 Abbreviations used: BBB, blood-brain barrier; PET, positron emission tomography; rCMRA, regional cerebral metabolic rate for ammonia.
The blood-brain barrier (BBB) is a unique aspect of cerebral anatomy. It serves as the functional in terface separating the brain from its blood supply (Rapoport, 1976) . All blood-borne compounds that affect brain function, such as metabolites and toxins, as well as waste products from cerebral me tabolism, must cross this barrier. Although quanti tative aspects of BBB function have been studied intensively in animals (Rapoport, 1976) , studies of barrier function in humans have been limited by methodology. We have developed methods, using positron emission tomography (PET), to evaluate the BBB to ammonia in humans.
Ammonia is a normal constituent of arterial blood, and, like many other molecules of biological importance, it crosses the BBB by passive diffu sion. It is cleared from arterial blood at a rate of � 1 mol/day in normal persons (Lockwood et aI., 1979) . About 7% of this amount is taken up and metabolized by the brain (Lockwood et aI. , 1979) . Hyperammonemia has been recognized as an im portant factor in the pathogenesis of hepatic en-g -I min -I in white matter. From literature values of the expected capillary surface area ratio, a gray-to-white matter ammonia permeability ratio of 0.37: 1.0 was cal culated. We speculate that astrocytes may mediate this unexpected difference in permeability, and that the per meability of the BBB to ammonia may be important in the pathogenesis of hyperammonemic brain dysfunction. Key Words: Ammonia-Blood-brain barrier-Cerebral blood f1ow-Diffusion-Positron emission tomog raphy -Radioi sotopes.
cephalopathy (Hoyumpa et aI., 1979) . Patients with chronic liver disease and encephalopathy almost al ways have elevated blood ammonia levels (Sher lock, 1958) and elevated brain ammonia metabolic rates (Lockwood et aI., 1979) . Recent studies using ll3N]ammonia have been aimed at evaluating the process related to the entry of ammonia into the brain. Ammonia uptake was shown by Lockwood et al. (1980) , as well as others (Raichle and Larson, 1981) , to be a function of the brain-blood pH gra dient. Other studies have shown that ammonia ex traction is reciprocally related to CBF (Phelps et aI. , 1977 (Phelps et aI. , , 1981 and proportional to the arterial am monia concentration (Cooper et al., 1979) . In this study, we report measures of the regional metabolic rate (rCMRA), extraction fraction, and perme ability -surface area products for ammonia in normal human subjects. A preliminary account of these studies has been presented (Lockwood et aI. , 1983) . Renkin (1959) and Crone (1963) have characterized the passive diffusion of compounds across capillary mem branes in terms of E, the fraction of a test substance extracted by the brain during a single transit through the capillary bed; F, blood flow through the capillary bed. in this case, CBF; P, the permeability of the capillary waJl to the test compound, here, the BBB; and S, the surface area of the BBB:
METHODS

Theoretical considerations
In the case of ammonia, we recognize that P represents the combined permeability of ammonia gas and the am monium ion as they exist in a pH-defined equilibrium. This model assumes that there is no back-diffusion of the test compound from brain back into the blood. The va lidity of this assumption and the applicability of this model to the study of ammonia uptake by the brain under most conditions have been demonstrated by Raichle and Larson (1981) . Phelps and associates have also investi gated ammonia uptake by the brain (Phelps et aI., 1981) . Although they agreed that there is no significant back diffusion of ammonia, they questioned the validity of the relationship shown in Eq. 1 when CBF is <0.20 ml g-I min -I, and proposed a saturation-recruitment modifica tion to account for what they presumed to be additional numbers of capillaries recruited as CBF increases. Phelps et al. (1981) produced low-flow conditions by brain com pression or embolization. Both manipulations have the potential for damaging the BBB and could cause P to increase. This could explain the deviations they observed from the behavior predicted by Eq. 1. Since this critical CBF threshold is far lower than we would expect to en counter in studies of normal subjects, and since Eq. I was used satisfactorily by Raichle and Larson (1981) , we have used it as the basis for our investigations.
The extraction fraction for ammonia is not measured easily in humans, since ammonia is consumed and ex creted by the brain (Lockwood et aI., 1979) . However, the extraction fraction can be calculated if the regional CBF and the rCMRA are known. The Fick equation states that
where a and v are the arterial and venous concentrations of ammonia. This equation can be solved for (av) in terms of F and rCMRA and substituted into the following definition of E:
The rCMRA can be measured in humans, without knowledge of F, by modifying the methods of Lockwood et al. (1979) , who reported the whole brain ammonia uti lization or metabolic rate in a series of normal subjects and patients with hyperammonemia, liver disease, and encephalopathy. Briefly, that method treats the brain as an infinite sink for labeled ammonia. This has been shown to be the case after either an intravenous (Lockwood et aI., 1979; Phelps et aI., 1981) or intracarotid (Phelps et aI., 1977) injection of [13Nlammonia. In an infinite sink model, the rate of ammonia entry into the brain is equal to the fraction of the total amount of the injected tracer trapped or metabolized by the brain divided by the rate of clearance of ammonia from the arterial blood pool (Shipley and Clark, 1972) . Clearance is easily measured using standard principles of tracer kinetics (Shipley and Clark, 1972) . Lockwood et al. (1979) used the methods of relative and absolute quantification to measure the amount of 13N trapped by the brain, and calculated clear ance from serial arterial blood specific activity measure ments made during the 10 min required for complete clearance of the [13Nlammonia from the arterial pool. Since ammonia is metabolized by body organs and re leased into the blood, a correction for nonammonia 13N must be made (Lockwood et aI., 1979) when the arterial ammonia specific activity is being determined.
The application of this method in the PET laboratory is relatively simple. The injected dose is measured in an ion chamber to determine the total amount of 13N admin istered. The PET image, with an appropriate decay cor rection, is a quantitative measurement of the tracer con tent in each pixel of the image, or volume element of the brain. For imaging times of 15 min that start 10 min after the intravenous injection of the tracer, radioactive decay is the only significant factor affecting brain tracer content (Lockwood et aI., 1979; Phelps et aI., 1981) . Thus, cal culating isotope content on a pixel-by-pixel basis with a decay correction back to the time of the injection is straightforward. This method for the measurement of rCMRA is very similar in principle to the method that Phelps et al. (1981) used to measure what they termed "net ammonia extraction." CBF can be measured by any appropriate method. We selected the method used by Ginsberg et al. (1982) and Raichle et al. (1983) . The validity of this method has been demonstrated (Ginsberg et aI., 1982; Raichle et aI., 1983) . It imparts a low dose of radiation to the subject (Kearfott, 1982) , and provides data that ensure a unique solution to the CBF operational equation (Howard et aI., 1983) .
Specific experimental methods
All protocols and procedures were approved by insti tutional review boards and the radioactive drug research committee (U.S. Food and Drug Administration). In formed consent was obtained from all subjects.
On the day of the investigation, subjects were brought to the PET suite, and a 20-gauge, Te flon, nontapered catheter was inserted into the radial artery under local anesthesia after an Allen test proved the adequacy of the ulnar arterial blood supply to the hand. An intravenous infusion was started in the other arm. The arterial cath eter was attached to an IntraFlo device (Sorenson Re search Co., Salt Lake City, UT, U.S.A.) that infused a heparinized saline irrigation solution through the catheter to maintain catheter and artery patency. The head was held firmly to prevent any movement during and between studies.
The CBF study was performed first, and was started when 25 mCi of [ISOlwater was injected as a bolus. Be tween 25 and 30 arterial blood samples were collected in tared tubes during the first 3 min after the injection. We recorded the time each sample was collected and timed the interval between the injection of the isotope and its arrival in the brain by monitoring bank-pair coincidence count rates. The PET camera data collection was started at the time of the injection, and appropriate corrections were made to relate the timing of blood and brain activity measurements (Raichle et aI., 1983) . No decay correction was applied to the PET data. Blood activity was mea sured in a well counter calibrated with reference to the PET camera, and a correction was made for the radio active decay occurring in the interval between sample collection and counting. All blood samples were weighed and converted to volume using a blood density correction factor of 1.05 glml.
The ammonia metabolism measurements were started ? 10 half-lives after the injection of the labeled water. The dose of [13N)ammonia was measured in calibrated ion chamber (Capintec), and an injection was made after a measured time interval, when decay to �20 mCi had oc curred. The residual 13N in the injection syringe was mea sured and subtracted to yield the exact dose of tracer administered. After the injection of the [13N)ammonia, a second set of arterial blood samples was collected. The total 13N content was determined, and the metabolized fraction was subtracted (Lockwood et al., J 979) . Decay corrections were made to the time of the injection. The arterial ammonia concentration was measured enzymat ically (Folbergrova et al., 1969) . PET imaging was started 10 min after the injection of the isotope; 15-min data col lection times were used.
PET imaging
A PETT V-type scanner designed by Te r-Pogossian et al. (1978) was used in the high-resolution mode. Random coincidences were subtracted by method 1 described by Hoffman et al. (1981) . Corrections for the absorption of annihilation photons were made by defining the head with an ellipse drawn at the boundary of the isotope activity and assuming a constant tissue attenuation coefficient, as described by Kuhl et al. (1976) . The system was cali brated daily by scanning a four-compartment phantom filled with measured amount of 6�Ga. The well counter was calibrated by counting a known dilution of the 6XGa from a compartment in the phantom.
Radiopharmaceutical preparation
13N was prepared by the 160(p,a)13N nuclear reaction in a water target. The target water was added to a reaction vessel containing Devarda's alloy and NaOH pellets to reduce oxides of 13N to ammonia gas, as described by Gelbard et al. (1975) . The [l3N)ammonia was trapped in physiological saline acidified by adding 0.1 N HCl. Prior to delivery to the patient area, the solution was neutral ized with 0.1 N NaOH and passed through a Millipore filter. [150)Oxygen was prepared by the 160(p, pn)150 nu clear reaction. The target gas was passed over a platinum catalyst along with H2 to form [150)water, which was trapped in ice-cold physiological saline (Ginsberg et al., 1982) . Prior to delivery to the patient area, the solution was passed through a Millipore filter.
Functional image construction
An image of the CBF was constructed from the arterial blood activity measurements and the PET image of in tegrated brain 150 activity, using the operational equation of Ginsberg et al. (1982) . The blood activity data were used to generate a look-up table that related blood flow to cumulative brain tracer content. The look-up table data were in turn used to transform the isotope distribution image into an image of CBF on a pixel-by-pixel basis.
The image of brain 13N content was converted to an image of rCMRA by dividing the isotope content for each pixel by the total amount of isotope injected. This quo tient was divided by the integral of the arterial specific activity for ammonia over the 10 min required to clear all labeled ammonia from the blood. The reSUlting rCMRA image was thus a linear transform of the isotope content image.
The ammonia extraction fraction image was generated by dividing each rCMRA value by its corresponding value for CBF, then dividing this quotient by the arterial am-J Cereb Blood Flow Metabol, Vol. 4, No.4, 1984 monia concentration as indicated in Eq. 3, which be comes E = rCMRA/(F x a). The subject's head was held in a constant position during the experimental period so that a given pixel always represented the same brain region, thus making this a simple computational problem.
Permeability-surface area product images were con structed from the images of the extraction fraction and CBF using Eq. I, which becomes PS = -In[(F -rCMRA)/a).
The adequacy of head positioning was verified in each study by a visual inspection of the extraction fraction and permeability-surface area product images. Head move ment would produce zero (or near-zero) divide errors or artifacts if a high cortical ammonia metabolic rate were divided by a very low extracerebral CBF value. These anomalies would be striking, and evident at the border of the brain and the extracranial space. Since these were not seen, constant head position was assumed.
For each subject, values for CBF, rCMRA, extraction fraction and permeability-surface area product were de termined in regions of interest selected in each frontal pole cortex (two regions of interest), four regions of the parietal cortex (two each on the right and left side), and bilaterally in the centrum semiovale (two regions of in terest). These regions were selected on the basis of a homogeneous appearance on the CBF image, in an at tempt to minimize unavoidable volume-averaging effects.
RESULTS
Examples of CBF, rCMRA, extraction fraction, and permeability-surface area product images in a single tomographic plane for a subject are shown in Fig. I. The mean values from the regions of interest from all five subjects are summarized in Ta ble 1.
As expected, CBF was highest in gray matter, with computed values that are comparable to those reported by Raichle et al. (1983) who used similar methods. Values for rCMRA were highest in gray matter and lowest in white matter. The ammonia extraction fraction was highest in low-flow areas and lowest in high-flow regions, corresponding to white and gray matter, respectively. For all regions of interest for each of the five subjects, the extrac tion fraction was plotted as a function of CBF. A linear reciprocal relationship was observed, with a mean slope of -0.47 ± 0.21 (± SD) and a mean correlation coefficient of 0.78. Permeability -sur face area product values were higher in gray than white matter, with a mean ratio of 1.22 ± 0.19: 1.00. Gray-to-white matter ratios for all variables were significantly different from 1.00 (p < 0.05) as shown by paired t tests for mean gray and white values for each subject.
DISCUSSION
We have developed a method for evaluating the diffusion of ammonia across the BBB in human sub jects, using PET. The method is somewhat general, lc,d iIiI�-.
FIG. 1. a: Positron emission tomography scan demonstrating regional CBF in a tomographic slice through the cerebral hemi spheres of a normal subject. b: Cerebral metabolic rate for ammonia. c: Ammonia extraction image. d: Permeability-surface area product image with arrows marking the brain boundary. CBF. ammonia metabolic rates, and permeability-surface area products were higher in gray than in white matter as shown by t tests (p < 0.05 for all three variables). Scale ranges are in all cases from zero to maxima of 0.94 cm3 g-l min-1 for CBF, <0.01 f,Lmol g-l min-1 for the ammonia metabolic rate (shown as 0.00 by the computer display), 0.74 for the ammonia extraction fraction, and 0.21 cm3 g-l min-1 for the permeability-surface area product. and could be applied to the investigation of other compounds with appropriate properties, if CBF and a non-CBF-dependent measurement of the regional metabolic rate of the compound are available.
To accept the 13N images as a reasonable repre sentation of the rCMRA, the 13N must enter the brain as ammonia, be metabolically trapped, and then remain in situ at a constant concentration during the study. Several reports have shown that [13N]ammonia is taken up by the brain. Cooper et al. (1979) have shown that this blood-borne am moma IS then converted to metabolites, primarily Values are means ± SD, and were obtained by sampling mUltiple re gions of interest in gray and white matter in positron emission tomography scans of five normal subjects. The variance in the extraction fraction (E) and the permeability-surface area product (PS) is due mainly to variance in the values of the regional cerebral mctabolic rate for ammonia (rCMRA), as shown by an analysis of variance. This variability was re duced in a calculation of the gray-to-white matter PS ratio, which was 1.22 ± 0.19: 1.00, a diffcrence that was significant by paired two-tailed I test (p < 0.05). In every case, white matter values for CBF, rCMRA, and PS were less than gray matter values, whereas E in white matter was always greater than in gray and was reciprocally related to flow.
glutamine, with a half-life of �3 s. The metabolic reactions that trap ammonia have such a high ca pacity that it has not been possible to demonstrate saturation of the process (Cooper et aI., 1979) or back-diffusion of the compound from the brain to the blood (Phelps et aI., 1981; Raichle and Larson, 1981) . Reported measures of cerebral 13N content after intravenous (Lockwood et aI., 1979) or intra carotid (Phelps et aI., 1977 (Phelps et aI., , 1981 injections of [13N]ammonia have shown that the cerebral tracer content is quite constant during our imaging time.
Although there are metabolites of [13N]ammonia in the blood during the experimental period, the trans BBB flux of nonammonia label occurs at a rate that is low, probably because the specific activity and the total transmembrane flux of the labeled metab olites (predominantly glutamine and urea) are very low. This would result in a low rate of nonammonia label movement, and would contribute to image sta bility and the validity of the method. For these rea sons, we believe that this strategy provides a valid measure of the rate at which ammonia is taken up from arterial blood and metabolized by the brain. The method underestimates the total brain am monia metabolic rate to the extent that the brain produces ammonia that is retrapped metabolically by the brain on the brain side of the BBB. This is an objection that could be raised to virtually any method, including measures of the glucose meta bolic rate made on the basis of arteriovenous con centration differences and CBF, because of the ef fect of glucose-6-phosphate dehydrogenase. Since there is a strong link between encephalopathy, ele vated arterial ammonia levels (Sherlock, 1958) , and whole brain ammonia utilization (Lockwood et aI., 1979) , this measure has potential importance in the study of these conditions. rCMRA values have not been reported for hu- Vol. 4 , No.4 , 1984 mans. However, the rates we measured conform well with those expected on the basis of the whole brain data reported by Lockwood et al. (1979) . Kuhl et al. (1980) have reported a gray-to-white matter ratio for 13N in brain, after an intravenous bolus injection of [13N]ammonia, that is identical to the ratio we observed. Since rCMRA is a linear trans form of the 13N content, the Kuhl data lend further credence to those that we report. Values for the regional ammonia extraction frac tion by the human brain have not been published; however, there are ammonia extraction fraction re ports in the literature for brains of rats, monkeys, and dogs (Phelps et al., 1977 (Phelps et al., , 1981 Lockwood et aI. , 1980; Raichle and Larson, 1981) . The extraction fraction values for ammonia in gray and white matter of dogs reported by Phelps et al. (1981) were lower than those we observed. Differences in spe cies, their use of pentobarbital anesthesia, and po tential pH differences owing to controlled ventila tion may be responsible for this discrepancy.
The ammonia extraction fraction has been shown to be reciprocally related to CBF by Phelps et a\. (1977 Phelps et a\. ( , 1981 and Raichle and Larson (1981) . Phelps et a\. (1981) manipulated CBF and measured the fractional extraction after each CBF change. Our study differs in that CBF was not manipulated. In stead, we obtained CBF and extraction fraction values from gray and white matter regions under physiological conditions that were verified as being normal by arterial blood gas measurements. Thus, we conclude that within normal brain, ammonia ex traction is a reciprocal function of CBF.
Permeability-surface area product images, gen erated as described above, represent a new appli cation of PET methodology and the study of the human brain. Whole brain permeability -surface area product values, computed with Eq. 1 but using different methods to measure CBF and fractional extraction, have been reported for monkeys and rats. The reported values are similar to those we obtained (Raichle and Larson, 1981; Lockwood et aI., 1983) . Phelps et al. (1981) modified Eq. 1 to produce a saturation recruitment model for the dif fusion of ammonia from cerebral capillaries, as de scribed in Methods. In spite of this difference, at basal CBF values, their value for the permeability surface area product of 0.32 ml g-I min -I compares very well with the value of 0. 32 + 0.19 ml g-I min -I that we report. Our white matter value of 0.24 ± 0.16 ml g-I min -I is higher than their value of 0.14 ml g-l min -J. The close similarity between our results, for which PET was used to measure brain isotope content, and those of Phelps et al. (1981) , who measured brain isotope content in ex cised samples, implies the validity of our methods and suggests that unavoidable errors owing to volume averaging can be minimized when regions of interest are chosen carefully.
Although there are no direct measurements of the surface area of the BBB to ammonia in the litera ture, the data of Cobb (1932) predict a gray-to-white matter capillary surface area ratio in humans of 3.3: 1. 0. These data, in conjunction with our per meability -surface area product data, enable us to calculate a gray-to-white matter permeability ratio of 0. 37: 1.00. This somewhat surprisingly lower gray matter permeability may help protect neuronal cell bodies from the toxic effects of ammonia, believed to be important in the pathogenesis of hepatic en cephalopathy, and may be relevant to the produc tion of other forms of hyperammonemic encepha lopathy. Since the enzymatic pathways responsible for the metabolism of ammonia in the brain are con fined to astrocytes (Martinez-Hernandez et al. , 1977) , and since these glia have foot processes that abut on cerebral capillaries, it is possible that as trocytes mediate the difference in gray and white matter ammonia permeability.
The BBB is a unique and important feature of the brain, yet we know little about the factors that in fluence its function, the potential for regional vari ability, how disease processes might affect it, and how barrier abnormalities might secondarily affect brain function. Increases in the permeability of the BBB to macromolecules are known to follow brain injury from stroke or freezing [see Rapoport (1976) for review]. Other recent data indicate that the BBB permeability to water is affected by central norad renergic tone and some antidepressant drugs (Raichle et aI., 1975; Preskorn et aI. , 1982) . These data suggest that the BBB is not a static, fixed entity, but may be modulated during normal or ab normal physiological processes. Our study demon strates that PET can be used to evaluate regional BBB permeability characteristics in humans. This ability to study the BBB without having to resort to imperfect animal models, while at the same time satisfying the ethical standards of contemporary clinical investigation, opens the door to significant advances in our understanding of this important as pect of cerebral physiology.
